It was not a particularly great day in the markets for investors in Healixa Inc (OTCMKTS:EMOR) as the company’s stock suffered from a selloff and ended the day with a decline of as much as 7%. In this situation, it may be a good time for investors to perhaps figure out if there is going to be a further selloff in the stock today or if there is going to be a recovery at some point.
Trading Data
On Thursday, EMOR stock fell 7.06% to $0.79 with 5.4K shares, compared to its average volume 7.8K shares. The stock moved within a range of $0.7750 – 0.8499 after opening trade at $0.8499.
About The Company
The best way to go about it is by taking a look at the nature of the company’s business and some of the recent developments related to it. Healixa is a tech company that is involved in the acquisition and building of disruptive and innovative technologies in a number of sectors.
Some of the sectors in which the company is involved include green tech, water generation, and health technology among others. The company deploys its patents, intellectual properties, partnerships, and collaborations for the purpose of creating a launch pad of disruptive technologies and solutions.
Healixa Strengthens Advisory Board with Appointment of Award-Winning Executive Satyajit Deb
The company had been in the news on Wednesday when it announced that it had decided to expand its advisory board with a new appointment. The latest addition to the Healixa advisory board is Satyajit Deb, an accomplished entrepreneur who has also been a senior executive for more than two decades.
In addition to that, Deb also boasts of considerable global experience and has performed a wide range of roles. He has worked in product development, marketing, business development, and innovation. Ian Parker, who is the Chief Executive Officer and Chairman of the company, spoke about the latest appointment as well. He noted that Deb was a major new addition to the advisory board considering the fact that he was going to bring a wealth of experience to the company.
He went on to add that Healixa was working towards the launch of its commercial operations in the upcoming months and Deb’s exemplary track record in the development, identification, and consummation of strategic alliances would be a major boost to the company. While the news was a significant one, it did not lead to any particular excitement among investors, and the stock actually suffered from a selloff. It will be interesting to see if investors change their minds with regards to the Healixa stock today or not.
Healixa Prepares Announces Appointment of Two Additional Independent Directors
In this situation, it is perhaps also necessary to point out that the company has working on shoring up its management for quite some time. For instance, last month on June 14, Healixa had come into the news cycle after it announced that it expanded its board of directors through the appointment of a pair of new independent directors.
One of those was Dong Yun and the other was Fig Annunziato. Ian Parker noted at the time that the appointments were made at a critical time since Healixa was making preparations for uplisting its stock to a national exchange. Investors could consider keeping an eye on the Healixa stock at this point.
Technical Data
EMOR stock is trading below the 20-Day and 50-Day Moving averages of $0.7103 and $0.7965 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.7387. The company has a total market capitalization of $6.68 million. The stock is down 25% over the past month.
